Gene · 623
Papers2,473
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 2,473
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ACE2/Ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease. | Clin Sci (Lond) | 2021 | 33511992 | PubTator, text mining | PubMed |
| Neurolysin substrates bradykinin, neurotensin and substance P enhance brain microvascular permeability in a human in vitro model. | J Neuroendocrinol | 2021 | 33506602 | PubTator, text mining | PubMed |
| Potentiation of B2 receptor signaling by AltB2R, a newly identified alternative protein encoded in the human bradykinin B2 receptor gene. | J Biol Chem | 2021 | 33497625 | PubTator, text mining | PubMed |
| Catecholaminergic Vasopressors Reduce Toll-Like Receptor Agonist-Induced Microvascular Endothelial Cell Permeability But Not Cytokine Production. | Crit Care Med | 2021 | 33481407 | PubTator, text mining | PubMed |
| Network analysis of Down syndrome and SARS-CoV-2 identifies risk and protective factors for COVID-19. | Sci Rep | 2021 | 33479353 | PubTator, text mining | PubMed |
| Significance of NETs Formation in COVID-19. | Cells | 2021 | 33466589 | PubTator, text mining | PubMed |
| Multifunctional angiotensin converting enzyme 2, the SARS-CoV-2 entry receptor, and critical appraisal of its role in acute lung injury. | Biomed Pharmacother | 2021 | 33461019 | PubTator, text mining | PubMed |
| Effects of vasopressin on anesthetic response time and circulatory dynamics of lidocaine. | Odontology | 2021 | 33449245 | PubTator, text mining | PubMed |
| Contact System Activation in Plasma from Dengue Patients Might Harness Endothelial Virus Replication through the Signaling of Bradykinin Receptors. | Pharmaceuticals (Basel) | 2021 | 33445640 | PubTator, text mining | PubMed |
| A survey on the application of oral propranolol and atenolol for the management of infantile hemangiomas in mainland China: Survey on propranolol atenolol hemangiomas. | Medicine (Baltimore) | 2021 | 33429792 | PubTator, text mining | PubMed |
| Novel modulators of p53-signaling encoded by unknown genes of emerging viruses. | PLoS Pathog | 2021 | 33411764 | PubTator, text mining | PubMed |
| Kinins and chymase: the forgotten components of the renin-angiotensin system and their implications in COVID-19 disease. | Am J Physiol Lung Cell Mol Physiol | 2021 | 33404363 | PubTator, text mining | PubMed |
| Filamentous recombinant human Tau activates primary astrocytes via an integrin receptor complex. | Nat Commun | 2021 | 33398028 | PubTator, text mining | PubMed |
| Predicting changes in renal metabolism after compound exposure with a genome-scale metabolic model. | Toxicol Appl Pharmacol | 2021 | 33387578 | PubTator, text mining | PubMed |
| A new storm on the horizon in COVID-19: Bradykinin-induced vascular complications. | Vascul Pharmacol | 2021 | 33358968 | PubTator, text mining | PubMed |
| Reply to Chan and Majluf-Cruz: Is the Angioedema Associated with COVID-19 a Real Entity, a Mimic, or Both? | Am J Respir Crit Care Med | 2021 | 33357023 | PubTator, text mining | PubMed |
| Targeting ACE2 for COVID-19 Therapy: Opportunities and Challenges. | Am J Respir Cell Mol Biol | 2021 | 33296619 | PubTator, text mining | PubMed |
| Correlation of matrix-related airway remodeling and bradykinin B1 receptor expression with fixed airflow obstruction in severe asthma. | Allergy | 2021 | 33284471 | PubTator, text mining | PubMed |
| A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor. | Pharmacol Ther | 2021 | 33275999 | PubTator, text mining | PubMed |
| Pathophysiology and underlying mechanisms in hereditary angioedema. | Balkan Med J | 2021 | 33233873 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/623/papers?page=30